Key result
Supraphysiologic shear rates cut platelet aggregate size ~71% compared to physiological shear.
Why the study?
The experimental effect of shear rate on platelet aggregation size, which may be directly relevant to bleeding complications during LVAD support, had not been reported.
Does exposure to supraphysiologic shear rates (>6000 s⁻¹) reduce the formation size of platelet aggregates and increase ADAMTS13-mediated HMW vWF multimer degradation compared to physiological shear rates (360-3000 s⁻¹) in human blood samples?
Does exposure to supraphysiologic shear rates (>6000 s⁻¹) reduce the formation size of platelet aggregates and increase ADAMTS13-mediated HMW vWF multimer degradation compared to physiological shear rates (360-3000 s⁻¹) in human blood samples?
Identifies a critical shear rate threshold between 3000 and 6000 s⁻¹ above which ADAMTS13-mediated vWF cleavage significantly reduces platelet aggregate size, offering a potential biomarker and design target to mitigate nonsurgical bleeding in LVAD patients.
Answers are grounded in this paper and cite their sources.
Supraphysiologic shear warrants LVAD design scrutiny to limit bleeding; leaves open prospective validation of shear thresholds.
Nonsurgical bleeding is the most frequent complication of left ventricular assist device (LVAD) support. Supraphysiologic shear rates generated in LVAD causes impaired platelet aggregation, which increases the risk of bleeding. The effect of shear rate on the formation size of platelet aggregates has never been reported experimentally, although platelet aggregation size can be considered to be directly relevant to bleeding complications. Therefore, this study investigated the impact of shear rate and exposure time on the formation size of platelet aggregates, which is vital in predicting bleeding in patients with an LVAD. Human platelet‐poor plasma (containing von Willebrand factor, vWF) and fluorochrome‐labeled platelets were subjected to a range of shear rates (0‐10 000 s −1 ) for 0, 5, 10, and 15 minutes using a custom‐built blood‐shearing device. Formed sizes of platelet aggregates under a range of shear‐controlled environment were visualized and measured using microscopy. The loss of high molecular weight (HMW) vWF multimers was quantified using gel electrophoresis and immunoblotting. An inhibition study was also performed to investigate the reduction in platelet aggregation size and HMW vWF multimers caused by either mechanical shear or enzymatic (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13—ADAMTS13, the von Willebrand factor protease) mechanism under low and high shear conditions (360 and 10 000 s −1 ). We found that the average size of platelet aggregates formed under physiological shear rates of 360‐3000 s −1 (200‐300 μm 2 ) was significantly larger compared to those sheared at >6000 s −1 (50‐100 μm 2 ). Furthermore, HMW vWF multimers were reduced with increased shear rates. The inhibition study revealed that the reduction in platelet aggregation size and HWM vWF multimers were mainly associated with ADAMTS13. In conclusion, the threshold of shear rate must not exceed >6000 s −1 in order to maintain the optimal size of platelet aggregates to “plug off” the injury site and stop bleeding.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2020) studied Shear-induced platelet aggregation and von Willebrand factor degradation (in vitro LVAD model) (n=5). Supraphysiologic mechanical shear rates (6000 and 10,000 s⁻¹) using a custom-built blood-shearing device, with or without 10 mM EDTA (ADAMTS13 inhibitor) vs. Physiological shear rates (360, 1000, and 3000 s⁻¹) and static control (0 s⁻¹) was evaluated on Formation size of platelet aggregates (μm²) at 15 minutes (p=<0.05). Supraphysiologic shear rates >6000 s⁻¹ reduced average platelet aggregate size to 50-100 μm² compared to 200-300 μm² under physiological shear rates of 360-3000 s⁻¹.
Synapse has enriched 10 related papers. Consider them for comparative context: